Correlation Between Partner Communications and Edgewise Therapeutics
Can any of the company-specific risk be diversified away by investing in both Partner Communications and Edgewise Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Partner Communications and Edgewise Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Partner Communications and Edgewise Therapeutics, you can compare the effects of market volatilities on Partner Communications and Edgewise Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Partner Communications with a short position of Edgewise Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Partner Communications and Edgewise Therapeutics.
Diversification Opportunities for Partner Communications and Edgewise Therapeutics
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Partner and Edgewise is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Partner Communications and Edgewise Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edgewise Therapeutics and Partner Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Partner Communications are associated (or correlated) with Edgewise Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edgewise Therapeutics has no effect on the direction of Partner Communications i.e., Partner Communications and Edgewise Therapeutics go up and down completely randomly.
Pair Corralation between Partner Communications and Edgewise Therapeutics
Assuming the 90 days horizon Partner Communications is expected to generate 1.3 times less return on investment than Edgewise Therapeutics. But when comparing it to its historical volatility, Partner Communications is 1.47 times less risky than Edgewise Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Edgewise Therapeutics is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest 1,788 in Edgewise Therapeutics on September 3, 2024 and sell it today you would earn a total of 1,512 from holding Edgewise Therapeutics or generate 84.56% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Partner Communications vs. Edgewise Therapeutics
Performance |
Timeline |
Partner Communications |
Edgewise Therapeutics |
Partner Communications and Edgewise Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Partner Communications and Edgewise Therapeutics
The main advantage of trading using opposite Partner Communications and Edgewise Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Partner Communications position performs unexpectedly, Edgewise Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edgewise Therapeutics will offset losses from the drop in Edgewise Therapeutics' long position.Partner Communications vs. Legacy Education | Partner Communications vs. Apple Inc | Partner Communications vs. NVIDIA | Partner Communications vs. Microsoft |
Edgewise Therapeutics vs. Seres Therapeutics | Edgewise Therapeutics vs. DiaMedica Therapeutics | Edgewise Therapeutics vs. Lyra Therapeutics | Edgewise Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |